Aberrant expression of microRNAs in bladder cancer
Author:
Publisher
Springer Science and Business Media LLC
Subject
Urology
Link
http://www.nature.com/articles/nrurol.2013.113.pdf
Reference102 articles.
1. Parkin, D. M., Bray, F., Ferlay, J. & Pisani, P. Global cancer statistics, 2002. CA Cancer J. Clin. 55, 74–108 (2005).
2. Ferlay, J., Parkin, D. M. & Steliarova-Foucher, E. Estimates of cancer incidence and mortality in Europe in 2008. Eur. J. Cancer 46, 765–781 (2010).
3. Zuiverloon, T. C. et al. Markers predicting response to bacillus Calmette-Guérin immunotherapy in high-risk bladder cancer patients: a systematic review. Eur. Urol. 61, 1245–1256 (2012).
4. Luke, C., Tracey, E., Stapleton, A. & Roder, D. Exploring contrary trends in bladder cancer incidence, mortality and survival: implications for research and cancer control. Intern. Med. J. 40, 357–362 (2010).
5. Meeks, J. J. et al. A systematic review of neoadjuvant and adjuvant chemotherapy for muscle-invasive bladder cancer. Eur. Urol. 62, 523–533 (2012).
Cited by 201 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. LncRNA BCYRN1 as a Potential Therapeutic Target and Diagnostic Marker in Serum Exosomes in Bladder Cancer;International Journal of Molecular Sciences;2024-05-29
2. Microbiome Sex-Related Diversity in Non-Muscle-Invasive Urothelial Bladder Cancer;Current Issues in Molecular Biology;2024-04-19
3. Amplification-Free Analysis of Bladder Cancer MicroRNAs on Wrinkled Silica Nanoparticles with DNA-Functionalized Quantum Dots;Analytical Chemistry;2024-03-13
4. MHGTMDA: Molecular heterogeneous graph transformer based on biological entity graph for miRNA-disease associations prediction;Molecular Therapy - Nucleic Acids;2024-03
5. CircFSCN1 induces tumor progression and triggers epithelial–mesenchymal transition in bladder cancer through augmentation of MDM2-mediated p53 silencing;Cellular Signalling;2024-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3